- NYSDOH AI Dear Colleague Letter: COVID-19 Prevention & Treatment for Patients with HIV: Vaccines and Nirmatrelvir/Ritonavir (Paxlovid) (10/11/22)
- HIVinfo: Updates to the Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV (9/21/22)
- NYSDOH Recognizes National HIV/AIDS and Aging Awareness Day, Highlighting New Programming (9/18/22)
- NYCDOHMH: Bivalent COVID-19 Boosters Recommended for Everyone Ages 12 Years and Older (9/17/22)
- FDA Takes Significant Action to Help Expand Access to Testing (9/7/22)
- HIVinfo: Updates to the Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV (9/7/22)
- HIVinfo: Updates to the Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Exposed and HIV-Infected Children (9/6/22)
- NYCDOHMH: Considerations for Monkeypox Testing of Pediatric Patients (9/1/22)
- HIVinfo: Updates to the Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV (9/1/22)
- FDA Authorizes Moderna, Pfizer-BioNTech Bivalent COVID-19 Vaccines for Use as a Booster Dose (8/31/22)